UiPath, Inc. PATH
12.46
(0.14)
(1.11%)
as of 25 Sep
- Market cap
- $6.6B
- P/E
- 18.6×
Follow PATH
Growth Flags
show if company had growth for consecutive years
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
37.49 | 23.98 | 17.08 | 19.04 |
P/S ratio |
5.44 | 4.19 | 3.22 | 3.85 | |
P/FCF ratio |
27.10 | 19.16 | 14.37 | 18.27 | |
P/Operating CF |
298.59 | 37.01 | 40.88 | 215.99 | |
P/B ratio |
4.39 | 3.24 | 2.83 | 3.40 | |
Price to Tangible BV |
4.74 | 3.48 | 3.33 | 3.98 | |
EV/Sales |
4.53 | 3.28 | 2.44 | 3.11 | |
EV/EBITDA |
63.30 | 30.52 | 17.97 | 18.30 | |
EV/Operating CF |
21.03 | 14.21 | 10.63 | 14.32 | |
EV/FCF |
22.61 | 14.98 | 10.88 | 14.73 | |
Quick Ratio |
2.24 | 2.17 | 1.93 | 1.97 | |
Current Ratio |
2.65 | 2.48 | 2.31 | 2.39 | |
Net Debt/EBITDA |
(32.96) | (12.04) | (22.22) | (18.78) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.56 | 0.53 | 0.60 | 0.63 | |
Operating CF/Net income |
0.14 | 1.75 | 5.86 | 0.85 | |
Capex/Depreciation |
(0.11) | (0.07) | (0.09) | (0.04) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
23.56% | 19.78% | 22.21% | 20.33% | |
Selling, General and Administrative Expense of Revenue |
56.52% | 48.17% | 52.72% | 52.33% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.10 | 0.10 | |
Share Based Compensation of Revenue |
17.39% | 13.48% | 12.74% | 10.96% | |
Graham Net Nets |
0.13 | 0.17 | 0.17 | 0.15 | |
Graham Number |
5.87 | 6.75 | 7.02 | 7.52 | |
Earnings Yield |
2.67% | 4.17% | 5.85% | 5.25% | |
Free Cash Flow Yield |
3.69% | 5.22% | 6.96% | 5.47% | |
Revenue per Share |
0.77 | 0.89 | 0.80 | 0.79 | |
Operating CF per Share |
0.05 | 0.34 | 0.25 | 0.06 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | 0.00 | |
Free Cash Flow per Share |
0.05 | 0.33 | 0.25 | 0.06 | |
Cash per Share |
2.63 | 2.74 | 2.50 | 2.47 | |
Shareholders Equity per Share |
3.62 | 3.87 | 3.63 | 3.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.62 | 3.87 | 3.63 | 3.75 | |
Free Cash Flow |
25.11 | 179.30 | 129.24 | 29.31 | |
Working Capital |
1,304.64 | 1,338.52 | 1,086.70 | 1,119.37 | |
Capital Expenditures |
(3.16) | (3.05) | (2.68) | (1.39) | |
Net Current Asset Value |
1,121.98 | 1,147.33 | 916.63 | 967.81 | |
EV/EBIT |
698.50 | 92.94 | 40.37 | 34.95 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 | |
Net Profit Margin |
48.37% | 21.71% | 5.38% | 8.80% | |
Price to Operating Income |
837.21 | 118.89 | 53.31 | 43.35 | |
| Other line items | |||||
Average Receivables |
351.45 | 469.70 | 283.31 | 288.46 | |
Average Payables |
16.35 | 21.67 | 18.29 | 18.30 | |
Average Assets |
2,779.63 | 3,022.24 | 2,774.57 | 2,749.84 | |
Average Common Equity |
1,828.23 | 1,964.17 | 1,800.71 | 1,807.13 |
Columns are period end dates